Codexis Inc. (NASDAQ:CDXS) went down by -7.65% from its latest closing price compared to the recent 1-year high of $32.42. The company’s stock price has collected 7.36% of gains in the last five trading sessions. Press Release reported on 09/09/21 that Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin
Is It Worth Investing in Codexis Inc. (NASDAQ :CDXS) Right Now?
Plus, the 36-month beta value for CDXS is at 1.40. Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Codexis Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $29.29, which is $1.63 above the current price. CDXS currently public float of 62.95M and currently shorts hold a 10.53% ratio of that float. Today, the average trading volume of CDXS was 491.49K shares.
CDXS’s Market Performance
CDXS stocks went up by 7.36% for the week, with a monthly jump of 20.77% and a quarterly performance of 53.59%, while its annual performance rate touched 104.47%. The volatility ratio for the week stands at 7.67% while the volatility levels for the past 30 days are set at 6.19% for Codexis Inc.. The simple moving average for the period of the last 20 days is 4.81% for CDXS stocks with a simple moving average of 20.31% for the last 200 days.
Analysts’ Opinion of CDXS
Many brokerage firms have already submitted their reports for CDXS stocks, with Piper Sandler repeating the rating for CDXS by listing it as a “Overweight.” The predicted price for CDXS in the upcoming period, according to Piper Sandler is $32 based on the research report published on April 12th of the current year 2021.
Stifel, on the other hand, stated in their research note that they expect to see CDXS reach a price target of $30. The rating they have provided for CDXS stocks is “Buy” according to the report published on March 01st, 2021.
H.C. Wainwright gave a rating of “Buy” to CDXS, setting the target price at $26 in the report published on February 26th of the current year.
CDXS Trading at 8.17% from the 50-Day Moving Average
After a stumble in the market that brought CDXS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.03% of loss for the given period.
Volatility was left at 6.19%, however, over the last 30 days, the volatility rate increased by 7.67%, as shares surge +21.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +38.24% upper at present.
During the last 5 trading sessions, CDXS fell by -2.35%, which changed the moving average for the period of 200-days by +37.86% in comparison to the 20-day moving average, which settled at $26.85. In addition, Codexis Inc. saw 38.25% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at CDXS starting from NICOLS JOHN J, who sale 35,000 shares at the price of $23.77 back on Aug 13. After this action, NICOLS JOHN J now owns 1,022,679 shares of Codexis Inc., valued at $831,796 using the latest closing price.
NICOLS JOHN J, the President and CEO of Codexis Inc., sale 35,000 shares at $24.53 during a trade that took place back on Aug 12, which means that NICOLS JOHN J is holding 1,022,679 shares at $858,546 based on the most recent closing price.
Stock Fundamentals for CDXS
Current profitability levels for the company are sitting at:
- -34.64 for the present operating margin
- +77.28 for the gross margin
The net margin for Codexis Inc. stands at -34.77. The total capital return value is set at -14.64, while invested capital returns managed to touch -14.87. Equity return is now at value -15.90, with -11.90 for asset returns.
Based on Codexis Inc. (CDXS), the company’s capital structure generated 14.67 points at debt to equity in total, while total debt to capital is 12.79. Total debt to assets is 11.26, with long-term debt to equity ratio resting at 13.12. Finally, the long-term debt to capital ratio is 11.45.
When we switch over and look at the enterprise to sales, we see a ratio of 16.94, with the company’s debt to enterprise value settled at 0.02. The receivables turnover for the company is 2.79 and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.38.